Now ideas for wellness

About Meiji

At a Glance

At a Glance

Get to know Meiji at a glance – from our core business to our most important numbers.

M&A and Alliances

As of Jun, 2021

Completed Acquisitions

Name of Acquirer Name of Acquiree Date of Acquisition Business
Meiji Seika Pharma Co., Ltd. Medreich Ltd. (India) Jun 2014 Contract manufacturing organization/
contract development and manufacturing organization
business and manufacturing and sale of pharmaceutical products

Joint Ventures

Meiji Group Licensee Alliance Partners Date Initiated Agreements
Meiji Seika Pharma Co., Ltd. Tjipto Pusposuharto and others (Indonesia) Mar 1974 Manufacturing and sales of
antibiotics and other pharmaceuticals
Nana Chart Traders Consolidation Ltd. and others (Thailand) Sep 1979 Manufacturing and sales of
antibiotics and other pharmaceuticals
Meiji Co., Ltd Bangkok IN-EX Co., Ltd.
Charoen Pokphand Group Co., Ltd. (Thailand)
Jan 1989 Commercialization partnership of
drinking milk, yogurt and others in Thailand
Meiji Seika Pharma Co., Ltd. Arysta Health & Nutrition Sciences Corp. (Japan) Feb 2011 Manufacturing and sales of
pharmaceuticals, agricultural chemicals and others
Dong-A Socio Holdings (Korea) Aug 2013 Research Collaboration on bio-similar products

Business Collaboration Agreements

Meiji Group Licensee Alliance Partners Date Initiated Agreements
Meiji Seika Pharma Co., Ltd. Taiho Pharmaceutical Co., Ltd. Dec 2015 Co-marketing Agreement in Japan for bilastine

Technical Alliances

In-Licensing
Meiji Group Licensee Alliance Partners Date Initiated Agreements
Meiji Co., Ltd. LB Bulgaricum
(Republic of Bulgaria)
May 2000 Licensing Agreement on Technical Assistance
Meiji Seika Pharma Co., Ltd. RaQualia (Japan) Mar 2011 Development and commercialization
partnership of Ziprasidone
Organon & Co. (USA) Mar 2013 Commercialization
partnership of Asenapine
Out-Licensing
Meiji Group Licensee Alliance Partners Date Initiated Agreements
Meiji Seika Pharma Co., Ltd. BASF Agrochemical
Products B.V. (the Netherlands)
May 2010 License agreement on ME5343
for world-wide development and
commercialization (except Japan)